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Abstract
The metabolic response of host cells, in particular of primary mammalian cells, to bacterial infections is poorly understood.
Here, we compare the carbon metabolism of primary mouse macrophages and of established J774A.1 cells upon Listeria
monocytogenes infection using 13C-labelled glucose or glutamine as carbon tracers. The 13C-profiles of protein-derived
amino acids from labelled host cells and intracellular L. monocytogenes identified active metabolic pathways in the different
cell types. In the primary cells, infection with live L. monocytogenes increased glycolytic activity and enhanced flux of
pyruvate into the TCA cycle via pyruvate dehydrogenase and pyruvate carboxylase, while in J774A.1 cells the already high
glycolytic and glutaminolytic activities hardly changed upon infection. The carbon metabolism of intracellular L.
monocytogenes was similar in both host cells. Taken together, the data suggest that efficient listerial replication in the
cytosol of the host cells mainly depends on the glycolytic activity of the hosts.
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Introduction
Adaptation of the bacterial metabolism to their host cells is a
crucial step in the replication cycle of intracellular bacterial
pathogens. This important aspect of pathogenesis of intracellular
bacteria has long been neglected, but has recently received
increased attention (for recent reviews see [1,2,3,4]). After
internalization by suitable host cells (mainly dendritic cells,
macrophages and epithelial cells), these bacteria are able to
actively replicate either in specialized membrane-surrounded
vacuoles, e.g. Salmonella enterica, Legionella pneumophila, Mycobacterium
tuberculosis, Chlamydia trachomatis, Brucella abortus, or - after escape
from the primary phagosome - in the host cell’s cytosol, e.g. Shigella
flexneri, Listeria monocytogenes, and Rickettsia prowazeki [5,6,7].
Whereas the latter bacteria in principle have direct access to most
nutrients taken up or produced by the host cells, the necessary
basic nutrients must be first transported across the impermeable
vacuolar membrane before they can reach vacuole-bound
bacteria. Although research on intracellular bacterial metabolism
is still in its infancy, the data already available suggest that each
intracellular bacterial pathogen adapts its metabolism to preferred
carbon and nitrogen sources offered by the host cells, which allows
not only intracellular bacterial replication but seems to optimize
also the expression of virulence factors essential for the intracel-
lular life cycle [2,3].
However, a possible flaw of these studies is that most of these
data were obtained with established epithelial and macrophage
cell lines. In contrast to the differentiated cells infected by the
intracellular bacteria during in vivo infections, the established cell
lines (used in the above mentioned studies) are cancer cells which
carry out a significantly altered metabolism. Most normal cells use
the tricarboxylic acid (TCA) cycle to produce ATP in the presence
of oxygen by oxidative phosphorylation (OXPHO). Although
OXPHO occurring in mitochondria provides more ATP than
glycolysis, the glycolytic pathway can produce ATP at a higher
rate [8]. The metabolism of cancer cells is subject to the ‘‘Warburg
effect’’ [9] resulting in enhanced glucose uptake and preferential
glucose catabolism via glycolysis even under normoxic conditions
(‘‘aerobic glycolysis’’). Pyruvate, the end product of glycolysis, is
converted to lactate under these conditions. Mitochondrial
conversion of pyruvate to acetyl-CoA is often strongly suppressed
and the metabolic flux through the TCA cycle, as well as aerobic
respiration via the electron transport chain (ETC) is inhibited
[10,11]. Thus, ATP is mainly generated in cancer cells by
enhanced glycolysis which favours - by increased glucose uptake -
fast rather than efficient energy production.
In addition, enhanced glutaminolysis, i.e. uptake and conversion
of glutamine to glutamate and further to a-ketoglutarate (a-KG) in
the mitochondria, is also frequently observed in cancer cells and
probably also in the established cell lines [12,13]. Glutaminolysis
feeds the mitochondrial TCA cycle leading to oxaloacetate (OAA)
which together with glucose-derived acetyl-CoA results in
enhanced citrate synthesis [14,15]. Citrate can be translocated to
the cytosol, where it is again broken down by ATP-dependent
citrate lyase (ACL) to cytosolic acetyl-CoA and OAA necessary for
the synthesis of fatty acids/lipids and amino acids (e.g. Asp),
respectively. Under hypoxic conditions, however, this TCA-cycle
dependent conversion of glutamine to citrate is strongly repressed
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due to the decreased formation of glucose-derived acetyl-CoA
[16]. As compensation, increased citrate production by carboxyl-
ation of a-KG, catalyzed by mitochondrial isocitrate dehydroge-
nase 2 (IDH2) can occur [17].
Induction of ‘‘core’’ metabolic host cell genes may occur by the
interaction with virtually all bacterial pathogens mainly via NF-kB
activation, triggered by pathogen-associated molecular patterns
(PAMPs) [18,19] and by interferon-gamma (IFN-c) [20,21].
However, whether and how intracellular pathogens manipulate
the host cell’s metabolism in a pathogen-specific fashion remains
by and large an open, yet crucial question. The metabolism of
mammalian cells is under the control of a complex regulatory
network consisting of several signalling pathways that converge in
the activation of several transcription factors, such as p53 [22,23],
Myc [24,25] and HIF-1 [25,26]. The three regulators control
(among others) the expression of multiple genes involved in the
uptake and metabolism of glucose and glutamine. These
transcription factors, but also amino acid sensors like mTORC1
[27] and other nutrient ‘‘transceptors’’ [28,29] controlling the host
cell metabolism, and the constitutive expression and/or the altered
activity of these regulatory components appear to be responsible
for the metabolic deregulation of most cancer cells. These
metabolic regulators may also represent potential host cell targets
for the interaction with specific virulence factors and effector
proteins of the bacterial pathogens and such interactions may lead
to the reprogramming of the host cell metabolism.
As a first step to evaluate the need and efficiency of
redistribution of resources between host cells and intracellular
bacterial pathogens, we compared in this study the carbon
assimilation of mouse bone marrow derived macrophages (BMM)
and of macrophage-like J774A.1 cells without and with infection
by L. monocytogenes using 13C-isotopologue profiling of amino acids.
Primary host cells (like BMM) are of special interest in this context
as they resemble more closely the target cells affected by in vivo
infections than the commonly used established cell lines (like
J774A.1). Recognition of specific metabolic host targets indis-
pensible for the proliferation of intracellular bacterial pathogens
may also provide novel approaches for antimicrobial interventions.
The data indicate that the expectedly different core carbon
metabolism of the two cell types is quite differently affected by
intracellular L. monocytogenes. In sharp contrast, the carbon
metabolism of the intracellular bacteria is similar in both host
cell types.
Results
Experimental Approach for the Determination of the
Basic Carbon Metabolism in Uninfected and Listeria
monocytogenes-infected Primary and Transformed
Murine Macrophages
13C-Isotopologue profiling of protein-derived amino acids is a
powerful technique to determine active pathways and metabolite
fluxes in living cells supplied with appropriate 13C-labelled carbon
sources, such as glucose (reviewed in [3,30]). To study possible
differences in the metabolic responses of primary and established
mammalian host cells to infection by intracellular bacterial
pathogens, we applied this method to uninfected and Listeria
monocytogenes-infected bone marrow macrophages derived from
C57BL/6 mice (in the following abbreviated BMM) and
macrophage-like J774A.1 cells derived from a murine reticulum
sarcoma [31].
Listeria monocytogenes was taken up by both host cell types with
similar efficiency (about 5% infected cells) and escape into the
cytosol occurred at similar times (latest 1 h post infection, pi). The
intracellular replication rates during the 8 h incubation period
apparently differed considerably (Fig. 1). Moreover, at the time of
harvest (8 h pi), the number of infected host cells increased up to
25% in J774A.1 cells, probably due to cell-to-cell spread of the
intracellular listeriae, but not in BMM. This results in a 5-fold
higher number of L. monocytogenes-infected J774A.1 cells (and
accordingly more intracellular bacteria) in comparison with L.
monocytogenes-infected BMMs. Since glucose and glutamine are the
most important carbon sources for proliferating mammalian cells,
uniformly 13C-labelled glucose ([U-13C6]glucose) or glutamine
([U-13C5]Gln) were used as precursors in experiments with
uninfected and infected host cells. Separation of the intracellular
bacteria and the host cells was performed as described previously
[32]. In both fractions, the 13C-isotopologue profiles of de novo-
synthesized (hence 13C-labelled) amino acids were determined
after hydrolyzing protein under acidic conditions. Since the
culture medium contained all amino acids, the biosynthesis of
amino acids requiring multiple enzymatic steps should be
repressed under these conditions. Indeed, 13C-incorporation
occurred mainly into Ala, Glu and Asp from the host cells whose
production requires only transamination of specific catabolic
intermediates, generated by glycolysis (Ala from pyruvate) or by
the TCA cycle (Asp from oxaloacetate (OAA) and Glu from a-
ketoglutarate (a-KG)). Hence, the 13C-enrichments in Ala, Asp,
and Glu reflect the cellular concentrations of the respective 13C-
labelled catabolic intermediates and therefore allow conclusions
concerning the activity of the metabolic pathways leading to these
intermediates in the uninfected and infected host cells.
Comparing the labelling profiles of amino acids from infected
and uninfected host cells, metabolic changes caused by the
intracellular cytosolically replicating L. monocytogenes could be
identified. To specifiy the impacts due to live L. monocytogenes,
13C-profiles of host cells treated with UV-inactivated L. monocyto-
genes or interferon-gamma (IFN-c) [33] were also determined.
Figure 1. Growth of L. monocytogenes EGDe in BMM (triangles)
and J774A.1 cells (circles). Bacterial growth was determined over a
period of 8 h post infection (pi). Indicated are the colony forming units
(cfu) after infection of 2x105 host cells with 5 bacteria per host cell. Each
experiment was done three times in triplicate. Values are means 6 SD
of one representative experiment. The generation times given in the
text were calculated from time point 1h pi to 8h pi for BMM and from
1h pi to 3h pi for J774A.1 host cells. Arrow indicates addition of
gentamicin.
doi:10.1371/journal.pone.0052378.g001
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13C-Profiles of Amino Acids from BMM Cells Cultured in
the Presence of [U-13C6]Glucose
In uninfected BMM cells, low 13C-incorporation occurred
mainly into Glu and Ala, when fed with [U-13C6]glucose for 8 h
(Fig. 2A). Under these conditions, [13C3]-Ala, [
13C1]-Asp, [
13C1]-
and [13C2]-Glu were predominantly formed (Fig. 2C), suggesting
that [U-13C6]glucose is converted at a low rate via the glycolytic
pathway to [13C3]-pyruvate (the precursor of [
13C3]-Ala), which is
further degraded by pyruvate dehydrogenase (PDH) to 13CO2 and
[13C2]-acetyl-CoA. The latter metabolite is channeled into the
TCA cycle and linked to unlabelled oxaloacetate (OAA – for
example derived from unlabelled Gln - see below) yielding [13C2]-
a-KG, the precursor of [13C2]-Glu (flux 1 in Fig. S1). Formation of
the [13C1]-isotopologues can be explained by carbon flux via
pyruvate carboxylase (PYC) involving 13CO2 as a substrate (flux 2
in Fig. S1).
Infection with live (and at a lower extent by UV-inactivated) L.
monocytogenes not only caused enhanced 13C-incorporation into Ala,
Asp and Glu (Fig. 2A), but also changed the isotopologue pattern
of Glu. Besides the major [13C2]-Glu species (formation via flux 1
in Fig. S1), [13C1]-, [
13C3]-, [
13C4]-, and even [
13C5]-Glu were
now also formed albeit in lower amounts (Fig. 2C). The 13C-a-KG
precursors required for these latter Glu isotopomers can be
generated by PYC- and PDH-catalyzed reactions with different
combinations of labelled and unlabelled pyruvate and CO2
leading to [13C1]-, [
13C3]-, [
13C4]-OAA, which in combination
with [13C2]-labelled and unlabelled acetyl-CoA (derived from
unlabelled Gln - see below) result in the formation of the [13C1]-,
[13C3]-, [
13C4]-, and [
13C5]-a-KG precursors (flux 2 in Fig. S1).
Under infection conditions, similar amounts of [13C1]-, [
13C2]-,
and [13C3]-Asp isotopologues were formed. The [
13C1]- and
[13C3]-Asp isotopologues require as precursors [
13C1]- and [
13C3]-
OAA, respectively, which are generated by ATP-dependent
pyruvate carboxylase (PYC) either from unlabelled pyruvate
(derived from unlabelled Gln - see below) and 13CO2 or from
[13C3]-pyruvate and unlabelled CO2 (flux 2 in Fig. S1).
13CO2
could originate either from the 13C-labelled pyruvate by PDH or
from decarboxylation of [13C6]-6-phosphogluconate in the pentose
phosphate pathway. The [13C2]-OAA precursor for [
13C2]-Asp is
formed in the TCA cycle by linking [13C2]-acetyl-CoA to
unlabelled OAA (again derived from Gln - see below) (flux 1 in
Fig. S1). In IFN-c-activated BMM, 13C-incorporation into Glu,
Asp and Ala slightly increased as compared to untreated BMM
(Fig. 2A).
The very weakly 13C-labelled amino acids Ser and Gly showed
the expected [13C3]-Ser and [
13C2]-Gly isotopologues, deriving
from the glycolytic intermediate [13C3]-3-phosphoglycerate. Nei-
ther infection of BMM by L. monocytogenes nor IFN-c activation
seem to change the rate of 13C-incorporation into the latter amino
acids in BMM.
Together, the data show that BMM cells exhibit low metabolic
activity, but viable L. monocytogenes (and to a lesser extent IFN-c and
UV-inactivated bacteria) enhance glycolysis leading to an
increased level of labelled pyruvate, which is channeled at
increased rates into the TCA cycle via the PDH- and PYC-
generated intermediates.
13C-Profiles of Amino Acids from J774A.1 Cells Cultured
in the Presence of [U-13C6]Glucose
Uninfected J774A.1 cells grown in the presence of [U-13C6]glu-
cose showed much higher 13C-incorporation into Glu, Ala and
Asp (up to 5-fold depending on the amino acid) than BMM
(Fig. 2B). 13C-Incorporation into Glu, Asp and Ala significantly
decreased in IFN-c-treated cells and slightly decreased upon
infection with live L. monocytogenes, but not with UV-inactivated L.
monocytogenes (Fig. 2B). This is in sharp contrast to 13C-incorpora-
tion into the same amino acids from BMM host cells, where
infection with L. monocytogenes leads to a considerable increase. This
suggests the presence of a highly active glucose-derived metabolite
flux through the glycolytic pathway already in the uninfected
J774A.1 cells and at least through those steps of the TCA cycle,
which are necessary for the generation of OAA and a-KG, the
intermediates for Asp and Glu. This flux is - in contrast to BMM -
not further activated by the L. monocytogenes infection. The 13C-
incorporation into Ser and Gly from uninfected and infected
J774A.1 cells was as low as in BMM cells (Fig. 2B).
Other than in BMM, the isotopologue distribution of J774A.1
amino acids did not significantly change upon infection with live
or killed L. monocytogenes or by treatment with IFN-c. Notably, the
13C-isotopologue patterns of Ala, Asp and Glu from uninfected
J774A.1 were quite similar to those from L. monocytogenes-infected
BMM cells (Fig. 2D), arguing for the generation of these
isotopologues by similar pathways in both cases (see above and
Fig. S1). Thus, the high level of [13C3]-Ala (deriving from [
13C3]-
pyruvate) indicates a high metabolite flux of the added
[U-13C6]glucose through the glycolytic pathway in J774A.1 cells.
The low amount of 13C-labelled Ser and Gly apparently derived
from the glycolytic intermediate [13C3]-3-phosphoglycerate. These
data again show that biosynthesis of amino acids that requires
more than only transamination of a glycolytic or TCA interme-
diate is repressed when the corresponding amino acid are
externally supplied, regardless whether the carbon metabolism is
low (as in BMM) or high (as in J774A.1).
Additionally and in contrast to the experiments with BMMs,
lower 13C-incorporation into the above mentioned amino acids
was observed when IFN-c activated J774A.1 cells were used,
indicating that IFN-c activation has a different effect on carbon
metabolism in the J774A.1 tumor cell line.
In summary, the results show that the glycolytic pathway and at
least the a-KG- and OAA-producing steps of the TCA cycle which
are also essential for anabolic processes (amino acid, nucleotide
and lipid biosynthesis) are highly active in J774A.1 cells. L.
monocytogenes infection hardly alters these metabolic steps.
13C-Profiles of Amino Acids from BMM and J774A.1 Cells
Cultured in the Presence of [U-13C5]Glutamine
Next, BMM and J774A.1 cells without or with infection by L.
monocytogenes were supplemented with 2 mM [U-13C5]Gln. In both
host cell types, the major amount of 13C-label was found - as
expected - in [U-13C5]Glu, indicating that most of the supplied
[U-13C5]Gln was directly incorporated into protein (Fig. 3).
Substantial 13C-incorporation was also found in Asp indicating
that Gln is in part used for replenishing the TCA cycle to support
anabolic reactions in uninfected and infected cells. Incorporation
into Asp from J774A.1 cells was about 3 to 5-fold higher compared
to incorporation into Asp from BMM cells (Fig. 3A and B). It can
be concluded that the anaplerotic reactions via glutaminolysis
were more active in J774A.1 cells.
In addition to the major [13C5]-Glu isotopologue, mainly
[13C3]-Glu and in small amounts also [
13C1]- and [
13C2]-Glu were
generated in BMM, as well as in J774A.1 cells. 13C-Asp
isotopologues were formed in the order
[13C4].[
13C1] = [
13C2].[
13C3] in BMM, but in the order
[13C4].[
13C3].[
13C2].[
13C1] in J774A.1 cells, suggesting that
some metabolic reactions were differently activated in the two cell
types. On the other hand, the 13C-isotopologue profiles of these
amino acids were not significantly changed by the L. monocytogenes
Metabolic Responses to Intracellular Listeria
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infection (Figs. 3C and 3D). Activation by IFN-c caused a slight
reduction (about 30%) of 13C-incorporation in viable J774A.1
cells, but not in BMMs.
Obviously, [13C5]-Gln is transported into the mitochondria
where it is converted to [13C5]-a-KG, [
13C4]-succinate, [
13C4]-
fumarate, [13C4]-malate, [
13C4]-OAA and
13CO2 in the TCA
cycle, running in the canonical direction (flux 1 in Fig. S2).
Unlabelled acetyl-CoA (deriving from the unlabelled glucose via
glycolysis) when linked to [13C4]-OAA yields [
13C3]-a-KG.
Indeed, this pathway leads to the major 13C-isotopologues of
Glu ([13C5] and [
13C3]) and Asp ([
13C4]), suggesting that it is
mainly used in BMM and J774A.1 cells. The fluxes 2, 3 and 4 in
Fig. S2 explain the formation of the other (minor) 13C
isotopologues of Glu and Asp. Of special interest is the generation
of [13C3]-Asp, which is the second major
13C-Asp isotopologue in
J774A.1, but not in BMM. This Asp isotopologue can be mainly
generated by flux 2 shown in Fig. S2, which is initiated by the
reductive carboxylation of a-KG to isocitrate catalyzed by
NADPH-dependent mitochondrial isocitrate dehydrogenase
(IDH2). This reverse IDH2 reaction has been demonstrated in
cancer cells [17,34] and obviously also occurs in J774A.1 cells.
Small, but well reproducible 13C-label was also observed in Ala,
Ser and Gly from both cell types (for numerical values, see Table
S1). These 13C-isotopologues were probably formed from inter-
Figure 2. 13C-Profiles of amino acids from host cells cultivated in the presence of [U-13C6]glucose. (A)
13C-Excess (mol %; displayed as a
color code) of amino acids derived from BMM cells; for each condition, two independent labeling experiments were performed. The color for each
amino acid correlates with the mean value of three MS determinations with the same sample. (B) 13C-Excess (mol %; displayed as a color code) of
amino acids derived from J774A.1 cells; for each condition, two independent labeling experiments were performed. The color for each amino acid
correlates with the mean value of three MS determinations with the same sample. (C) Relative isotopologue composition of amino acids derived from
BMM. Colored columns indicate the % amounts of isotopologues comprising 1, 2, 3, 4, or 5 13C-atoms (M+1 to M+5; left scale; * indicate values from
only one labeling experiment; otherwise, the values represent means from two labeling experiments). 13C-Excess values are shown as grey columns
(mol %, right scale; error bars indicate SD for two independent labeling experiments). (D) Relative isotopologue composition of amino acids derived
from J774A.1 cells. Colored columns indicate the % amounts of isotopologues comprising 1, 2, 3, 4, or 5 13C-atoms (M+1 to M+5; left scale; the values
represent means from two labeling experiments). 13C-Excess values are shown as grey columns (mol %, right scale; means from two independent
labeling experiments; error bars indicate SD for the two labeling experiments). Experiments were done with and without infection by Listeria
monocytogenes (L.m.) and with (+) and without (-) activation by interferon-c (IFN-c). The color maps indicate 13C-excess in semi-logarithmic form to
show even relatively small 13C excess values; for numerical values, see also Table S1.
doi:10.1371/journal.pone.0052378.g002
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mediates generated by gluconeogenesis starting from [13C4]-OAA
(flux 1). Infection by L. monocytogenes again hardly changed the rates
of 13C-incorporation into these amino acids in the two cell types.
In summary, glutaminolytic activity in BMM cells is similarly
low as the glycolytic activity. Flux through glutaminolysis remains
low upon L. monocytogenes infection. In contrast, glutaminolysis is
much more active in J774A.1 cells and might be even slightly
inhibited by the L. monocytogenes infection.
13C-Profiles of Amino Acids from L. monocytogenes
Replicating in BMM or J774A.1 Cells
Regardless whether the bacteria replicated in BMM or J774A.1
cells, the same bacterial amino acids (in the order
Ala.Asp.Thr.Glu.Ser.Tyr.Lys.Gly) were 13C-labelled in
the presence of [U-13C6]glucose (Fig. 4A, for numerical values, see
Table S2). Even the absolute 13C-enrichment values and the
isotopologue patterns (Fig. 4C) were similar in amino acids from L.
monocytogenes, irrespective of growth in BMM or J774A.1 cells. This
indicates that in both host cells the same glucose-derived carbon
sources were used and metabolized in a similar way by
intracellular L. monocytogenes (see key reactions highlighted in
orange in Fig. 5). In IFN-c-treated BMM cells, no change of the
rate of 13C-incorporation into the amino acids and of the 13C-
isotopologue patterns was observed, whereas a 2-fold reduction in
the rate of 13C-incorporation into the amino acids occurred in
IFN-c-treated J774A.1 cells (Fig. 4A).
In the presence of [U-13C5]-Gln, L. monocytogenes replicating in
BMM incorporated substantial amounts of [13C5]-Glu/Gln into
Figure 3. 13C-Profiles of amino acids from host cells cultivated in the presence of [U-13C5]glutamine. (A)
13C-Excess (mol %) of amino
acids derived from BMM cells, (B) 13C-Excess (mol %) of amino acids derived from J774A.1 cells, (C) Relative isotopologue composition of amino acids
derived from BMM. (D) Relative isotopologue composition of amino acids derived from J774A.1 cells. For more details, see legend to Figure 2; for
numerical values, see also Table S2.
doi:10.1371/journal.pone.0052378.g003
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Figure 4. 13C-Profiles of amino acids from Listeria monocytogenes replicating in BMM or J774A.1 host cells. (A) Experiment with
[U-13C6]glucose.
13C-Excess (mol %) displayed as a color map. (B) Experiment with [U-13C5]glutamine.
13C-Excess (mol %) displayed as a color map. (C)
Relative isotopologue compositions. Colored columns indicate the % amounts of isotopologues comprising 1, 2, 3, 4, or 5 13C-atoms (M+1 to M+5;
left scale). 13C-Excess values are shown as grey columns (mol %, right scale); for numerical values, see also Tables S1 and S2.
doi:10.1371/journal.pone.0052378.g004
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bacterial protein (Figs. 4B and 4C), but apparently did not
metabolize [13C5]-Glu/Gln further, since no other amino acid,
except Pro which derives directly from Glu, acquired significant
13C-label. This is not unexpected, since L. monocytogenes lacks a-
ketoglutarate dehydrogenase which should be necessary for
channeling [13C5]-Glu/Gln as carbon source into the listerial
TCA cycle. L. monocytogenes replicating in J774A.1 incorporated
considerably less [13C5]-Glu/Gln into protein (Fig. 4B). IFN-c
inhibited the formation of [13C5]-Glu/Gln in L. monocytogenes when
Figure 5. Reconstructed metabolite fluxes originating from glucose or glutamine in BMM (A) and J774A.1 cells (B) with or without
infection by L. monocytogenes. Black arrows indicate glucose-derived fluxes. Line widths indicate the approximate activities through these
reactions. Green arrows indicate fluxes via glutaminolysis. Red arrows display flux modulations due to infection with L. monocytogenes. Bacterial
pathways are highlighted in orange. The listerial metabolism is mainly fed by host cell derived [U-13C3]glycerol (deriving from [U-
13C6]glucose) and
[U-13C6]glucose 6-phosphate as described before [32]. The
13C-labelled intermediates for the formation of the major 13C-amino acid isotopologues
derive from glycolytic reactions to pyruvate which is converted by PDH to Ac-CoA. The latter intermediate is channeled into the TCA cycle yielding
together with OAA citrate and further to a-KG. OAA is produced by PYC-catalyzed carboxylation of pyruvate due to the disrupted listerial TCA cycle
[47] which is also the reason for the inability of L. monocytogenes to catabolize [U-13C5]glutamine.
doi:10.1371/journal.pone.0052378.g005
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the bacteria replicated in J774A.1 cells, but not when they
replicated in BMM cells (Figs. 4 B and 4C).
These data show that the carbon metabolism of intracellularly
growing L. monocytogenes is similar in BMM and J774A.1 and
mainly depends on the glycolytic activity of the host cells, while the
glutaminolytic activity does not seem to affect the listerial carbon
metabolism.
Discussion
Glucose and glutamine are the major carbon sources providing
energy and intermediates for anabolic processes to proliferating
mammalian cells via glycolysis, the pentose phosphate shunt,
glutaminolysis and the TCA cycle. 13C-Isotopologue profiling
using [U-13C6]glucose or [U-
13C5]glutamine was applied to
determine the carbon pathways in primary murine bone marrow
macrophages (BMM) and the established murine macrophage cell
line J774A.1. The activities in the core carbon metabolism of the
two cell types turned out to be quite different. Glycolytic and
glutaminolytic activities were low in BMMs, but high in neoplastic
J774A.1 macrophages (cf. line widths of black and green arrows in
Fig. 5), which is a typical feature (‘‘Warburg effect ‘‘) of many
cancer cells [11,13].
The enhanced metabolic activities in J774A.1 cells can be
explained by the fact that this cell line derives from a mouse tumor
expressing c-Myc constitutively [35]. This transcription factor
causes up-regulation of the genes for the glucose transporter
GLUT1, several glycolytic enzymes and lactate dehydrogenase
(LDH-A) [25,36,37]. Myc also induces a transcriptional program
that promotes glutaminolysis by increasing the level of a glutamine
transporter and mitochondrial glutaminase (GLS) [38], leading to
cell adaptation to glutamine as a bioenergetic substrate. Indeed,
the carbon metabolism of J774A.1 cells, deduced from the 13C-
profiles of Ala, Glu and Asp, displayed the expected Myc-induced
glycolytic and glutaminolytic pathways [23,24]. Interestingly,
substantial reductive carboxylation of glutamine-derived a-KG
to citrate, catalyzed by the mitochondrial IDH2, occurred in
J774A.1 cells, but not in BMM under any of the described
experimental conditions. This reaction, running in the opposite
direction to the canonical TCA cycle has also been previously
observed in cancer cells [34]. It generates citrate for anaplerosis
under hypoxic conditions and appears to be HIF-1-regulated
under these conditions [17].
Interestingly, the metabolic patterns in J774A.1 were hardly
altered by infection with live (or killed) L. monocytogenes, suggesting
that the carbon metabolism of J774A.1 cells is already appropriate
for efficient intracellular metabolism of L. monocytogenes. IFN-c led
to an apparent reduction of the glycolytic and the glutaminolytic
activities which may be due to enhanced production of reactive
oxygen species (ROS) causing reduced viability of these host cells
[39].
In sharp contrast, infected BMM cells showed a strongly
increased glycolytic activity (red arrows in Fig. 5) in comparison
with uninfected BMM cells, whereas carbon flux via glutaminolysis
remained low. Taking into consideration the relatively low portion
of infected cells in the L. monocytogenes-treated BMM population
(see above), the increment in metabolic induction caused by the
intracellular L. monocytogenes should be even higher than expressed
by the reported experimental numbers. Activation by IFN-c or
UV-killed L. monocytogenes induced a similar flux modulation, albeit
at a considerably lower level.
The IFN-c-mediated relatively low induction may be due to
enhanced expression of inducible nitric oxide synthase (iNOS or
NOS2) [40,41]. The thereby increased amount of NO activates
glucose uptake and glycolysis in macrophages and other cells [42].
Similar iNOS induction has also been shown for live and killed
bacteria by PAMP-induced NF-kB activation [19] and may
explain the slight increase of metabolic activity by UV-inactivated
bacteria. The high induction of glycolysis in BMM observed with
live L. monocytogenes requires, however, not only uptake of the
listeriae (which is similar for the live and UV-inactivated L.
monocytogenes), but also release of the bacteria into the host cell’s
cytosol (which occurs with live but not with UV-inactivated L.
monocytogenes). The thereby triggered induction of host cell
glycolysis could be caused by HIF-1 activation (via stabilization
of the HIF-1a subunit) and is indeed frequently observed during
infections with extra- and intracellular bacterial pathogens [43,44].
However, activated HIF-1 blocks PDH activity (through activation
of PDH kinase, [45]) and thus inhibits the TCA cycle. On the
other hand, the induced de novo synthesis of Glu and Asp in BMM
(particularly when infected by live L. monocytogenes) requires active
pyruvate dehydrogenase (PDH), pyruvate carboxylase (PYC),
citrate synthase (CS), isocitrate dehydrogenase (probably IDH1
and IDH2), ATP-dependent citrate lyase (ACL) and malic enzyme
(ME). Hence, PDH must be active in the infected BMMs which
becomes particularly evident by the increased production of
[13C2]-Glu as major
13C-Glu isotopologue species in the infected
BMM cells when cultured in the presence of [U-13C6]glucose.
Generation of this Glu isotopologue requires [13C2]-acetyl-CoA
that can only be produced by PDH from [U-13C6]glucose-derived
[13C3]-pyruvate. Thus, HIF-1 is probably not responsible for the
highly induced glycolysis in BMMs when infected with live L.
monocytogenes and it remains an intriguing question which host cell
regulator is responsible for this induction and which listerial factor
triggers it. Listeriolysin might be a candidate on the listerial side
[46].
Notably, the carbon metabolism of the intracellular L.
monocytogenes, deduced from the 13C-profiles of the labelled amino
acids by [U-13C6]glucose, was similar in BMM and J774A.1.
Substantial 13C-incorporation did not only occur into bacterial
Ala, Glu and Asp, but also into Ser, Gly, Pro, Thr and Lys,
indicating that the intracellular listeriae sense the obviously low
level of these latter amino acids in the host cell cytosol, whereas the
host cells sense, as expected, the high external amino acid
concentrations. The bacterial carbon metabolism is apparently not
influenced by the highly different efficiency of glutamine uptake
and consumption by the two host cell types. This may be due to
the missing a-ketoglutarate dehydrogenase [47] and the inefficient
uptake of OAA and Asp [48] into L. monocytogenes, rendering its
catabolism insensitive to glutamine. As shown previously [32],
intracellular L. monocytogenes seem to prefer glycerol and glucose 6-
phosphate as carbon sources provided by the host cell. Indeed, the
availability of these carbon compounds depends only on the
glycolytic but not on the glutaminolytic activity of host cells.
In summary, the data show that L. monocytogenes infections
modifies the metabolism of primary host cells (at least of BMM)
with an a priori inadequate metabolism for listerial replication in
such a way that it becomes appropriate for the intracellular
metabolism of these bacteria.
Materials and Methods
Bacterial Strains, Macrophage Cells and Growth Media
L. monocytogenes strain EGDe and the used murine macrophage-
like cell line J774A.1 were described before [32]. Primary C57BL/
6 mouse macrophages were obtained from the bone marrow and
differentiated to CD11b+, CD11c-, F4/80+ macrophages in
Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 g/l
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glucose, 110 mg/l sodium pyruvate and supplemented with 2 mM
glutamine, 10 mM HEPES, 10 mg/l recombinant murine mac-
rophage colony-stimulating factor (M-CSF), 10% FCS and 5%
horse serum for 8 to 10 days; fresh medium was added every 3
days. Mice were cared for in accordance with the principles
outlined by the European Convention for the Protection of
Vertebrate Animals Used for Experimental and Other Scientific
Purposes (European Treaty Series, no. 123; http://conventions.
coe.int/Treaty/en/Treaties/Html/123). All animal experiments
were in compliance with the German animal protection law and
were approved (permit no. 03-001/08) by the responsible Federal
State authority and ethics committee. The isolation and use of
mouse macrophages were approved by the responsible Federal
State authority (AZ 55.2-1-54-2531.6-14-02).
Growth Conditions and Infection
L. monocytogenes was grown in BHI at 37uC with aeritation to an
OD600 < 1. Then, the culture was centrifuged at 7,0006 g and
washed two times with ice-cold PBS. Aliquots resuspended in PBS
containing 20% (v/v) glycerol were frozen at -80uC and used for
later infection. The differentiated mouse primary macrophages
(BMM) and the J774A.1 cells were seeded in 24 hole plates at cell
densities of 26105 and 16105 cells per hole, respectively, and
incubated overnight to allow adherence of the macrophages.
BMM and J774A.1 cells were infected with L. monocytogenes EGDe
(5 bacteria per host cell) resuspended in RPMI medium with 10%
FCS and 10 mM recombinant human insulin to enhance glucose
uptake by BMM [49]. Infection was synchronized by centrifuga-
tion at 1736 g and 37uC for 5 min. After 60 min of incubation,
the medium was replaced by RPMI containing additionally
50 mg/ml gentamicin to kill extracellular bacteria. This was
defined as time point 0 post infection (pi). Under these conditions,
up to 5% of the BMM and J774A.1 cells contained intracellular
bacteria. Intracellular bacterial growth was measured over a
period of 8 h by lysing the cells in distilled water and counting the
released viable bacteria by plating them on BHI agar plates.
13C-Labelling Experiments
26106 BMM and 16106 J774A.1 cells, respectively, were
seeded in culture plates (Ø 10 cm), containing medium supple-
mented with unlabelled substrates, 20 ng/ml interferon-gamma
(IFN-c) where indicated, and incubated for 24 h. Infection was
carried out as described above with L. monocytogenes EGDe at a
MOI of 5. As controls, an equal number of host cells remained
uninfected or were infected with UV-inactivated L. monocytogenes (5
bacteria per host cell). After 30 min of gentamicin-treatment, the
medium was replaced by fresh RPMI now containing additionally
10 mM [U-13C6]glucose (without unlabelled glucose, but 2 mM
unlabelled glutamine) or 2 mM [U-13C5]glutamine (no unlabelled
glutamine, but 10 mM unlabelled glucose). At 8.5 h pi, cells were
washed with PBS buffer and lysed in 1 ml ice-cold distilled water
containing 0.1% TritonX-100, 10 mM sodium azide, 5 mg/ml
tetracycline and 50 mg/ml chloramphenicol for 10 min. The lysate
was vigorously vortexed and the bacteria were pelleted at 25,000
6 g. The bacteria-free supernatant was frozen (in liquid nitrogen).
The bacterial pellet was washed with RIPA buffer [50],
recentrifuged and frozen in liquid nitrogen without resuspending
it.
Protein Hydrolysis and Amino Acid Derivatization
Protein-containing samples (i.e. bacteria-free supernatant or
bacterial pellet, see above) were heated in 6 M HCl for 24 h at
105uC. Under these conditions, protein-derived Gln and Asn were
converted into Glu and Asp, respectively. Trp and Cys were
destroyed by this treatment. HCl was evaporated under nitrogen
and the pellet was dissolved in 50% acetic acid. Separation and
purification of the protein-derived amino acids was performed via
a cation exchange column of Dowex 50Wx8 (H+-form, 200–400
mesh, 56100 mm), washed with water and developed with 4 M
ammonium hydroxide. The eluate was dried under nitrogen, and
the residue dissolved in 50 ml water-free acetonitrile. A mixture of
50 ml of N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide
containing 1% tert-butyldimethylsilylchloride (Sigma) was added.
The derivatization took place at 70uC for 30 min. The resulting
N-(tert-butyldimethylsilyl) (TBDMS)-amino acids were then mea-
sured via GC/MS. The yields of TBDMS-Arg and TBDMS-Met
were low. Therefore, isotopologue data of theses amino acids are
typically not listed.
Gas Chromatography/mass Spectrometry (GC/MS)
GC/MS was performed on a GC 2010 (Shimadzu, Duisburg,
Germany) equipped with a fused silica capillary column (Equity
TM-5; 3060.25 mm film thickness; SUPELCO, Bellefonte, PA)
and a quadrupol QP2010 plus detector (Shimadzu) working with
electron impact ionization at 70 eV. The derivatized sample was
injected in a 1:10 split mode at an interface temperature of 260uC
and a helium inlet pressure of 70 kPa. The GC-column was
developed at 150uC for 3 min and then with a temperature
gradient of 7uC/min to a final temperature of 280uC which was
held for 3 min. With a sampling rate of 0.5 s, selected ion
monitoring was used. Data collection proceeded via GC/MS
Solution software (Shimadzu). All samples were measured three
times. 13C-Excess and isotopologue abundances were calculated
according to standard procedures [51,52] including: (i) determi-
nation of the TBDMS-derivate spectrum of derivatized amino
acids, (ii) determination of mass isotopologue distributions of
labelled TBDMS-amino acids, and (iii) correction for 13C-
incorporation concerning the heavy isotope contributions due to
the natural abundances in the TBDMS-moiety and the amino acid
atoms. The data for listerial amino acids were normalized by
subtracting the contributions from host cell protein due to minor
contamination of the bacterial pellet with host cell membrane
fragments.
Supporting Information
Figure S1 Reconstructed metabolic fluxes based on the
13C-labelled amino acid isotopologues deriving from
[U-13C6]glucose. Flux 1 describes the formation of [
13C3]-Ala,
[13C2]-Asp and [
13C2]-Glu isotopologues by glycolysis and the
canonical TCA cycle using unlabeled OAA (deriving from
glutamine) and [13C2]-Ac-CoA from [U-
13C6]-glucose. Flux 2
describes the formation of the [13C1]-, [
13C2]- and [
13C3]-Glu
isotopologues and of the [13C1]-, [
13C3]-, and [
13C4]-Asp
isotopologues via glycolysis, PYC-derived 13C-labeled OAA
intermediates and unlabeled Ac-CoA (from glutamine-derived
pyruvate (Pyr). The intermediates deriving from citrate are
converted to the corresponding 13C-Asp and 13C3-Glu isotopolo-
gues by ACL and ICD-1 and ICD-2, respectively. Intermediates
predominantly deriving from 13C-glucose are written in red letters,
while those predominantly deriving from unlabeled glutamine are
in black letters and those deriving from 13C-glucose and unlabeled
glutamine in green letters. The red dots indicate the number of
13C-atoms in the respective compound.
(TIF)
Figure S2 Reconstructed metabolic fluxes based on the
13C-labelled amino acid isotopologues deriving from
[U-13C5]glutamine. Flux 1 shows the formation of [
13C5]-,
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[13C3]-Glu and [
13C4]-Asp via glutaminolysis, TCA cycle
reactions, and ACL-catalyzed reaction to [13C4]-OAA. Interme-
diates deriving predominantly from [U-13C5]glutamine are written
in blue letters, while those deriving predominantly from unlabelled
glucose are in black letters and those deriving from [U-13C5]glu-
tamine and unlabelled glucose in green letters. Flux 2 shows the
formation of [13C5]-Glu and [
13C3]-Asp isotopologues via
glutaminolysis, citrate production by isocitrate dehydrogenase
(ICD2)-dependent carboxylation of a-KG and citrate conversion
to a-KG and OAA by cytosolic ACL and ICD1. Intermediates
deriving predominantly from [U-13C5]glutamine are written in
blue letters, while CO2 as well as the intermediates deriving
predominantly from catabolism of unlabelled glucose are in black
letters and those deriving from [U-13C5]glutamine and unlabelled
CO2 are in green letters. Flux 3 describes the formation of [
13C2]-
Glu, [13C2]- and [
13C4]-Asp isotopologues via glutaminolysis,
canonical TCA cycle reactions to [13C4]-malate, conversion to
[13C3]-pyruvate and
13CO2 generation of [
13C2]-Ac-CoA by
PDH, condensation to unlabelled OAA (from unlabelled glucose)
yielding [13C2]-citrate which is further converted by ACL to
[13C2]-OAA and by ICD1 to [
13C2]-a-KG. Flux 4 describes the
formation of [13C1]-Glu and [
13C1]-Asp isotopomers via glutami-
nolysis, canonical TCA reactions yielding (among other interme-
diates) 13CO2 which is used for PYC-catalyzed carboxylation of
unlabelled pyruvate to [13C1]-OAA, giving rise together with
unlabelled Ac-CoA (from unlabelled Glc) to [13C1]-citrate and
further to [13C1]-OAA and [
13C1]-a-KG. The blue dots indicate
the number of 13C-atoms in the respective compound. For further
details and abbreviations, see main text.
(TIF)
Table S1 13C-Isotopologue abundance in mol% of
protein derived amino acids from experiments with
uninfected and Listeria monocytogenes-infected BMM
and J774A.1 macrophages with 11 mM [U-13C6]glucose
and with or without IFN-c. (I) and (II) represent two biological
experiments. Isotopologues are described by an extended binary
code: 1 represents a 13C-atom, 0 stands for 12C, X is unknown. Y
is unknown, but for a given number (outside the brackets) it
represents a 13C-atom. Data from host cells represent mean values
of three measurements (with S.D.) of cell lysate. Data from
intracellular Listeria monocytogenes represent calculated values of the
bacterial fraction (spill over factor of host cell pellet was
determined as described under Methods); n.d. means not
determined.
(PDF)
Table S2 13C-Isotopologue abundance in mol% of
protein derived amino acids from experiments with
uninfected and Listeria monocytogenes-infected BMM
and J774A.1 macrophages with 2 mM [U-13C5]glutamine
and with or without IFN-c. (I) and (II) represent two biological
experiments. Isotopologues are described by an extended binary
code: 1 represents a 13C-atom, 0 stands for 12C, X is unknown. Y
is unknown, but for a given number (outside the brackets) it
represents a 13C-atom. Data from host cells represent mean values
of three measurements (with S.D.) of cell lysate. Data from
intracellular Listeria monocytogenes represent calculated values of the
bacterial fraction (spill-over factor of host cell pellet was
determined as described under Methods); n.d. means not
determined.
(PDF)
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